Through dedicated protein and peptide engineering efforts, we managed to create the first ever oral biologic of its kind - oral semaglutide for type 2 diabetes launched in 2019
Sun Pharma rolled out pricing for its two brandsNoveltreat and Sematrinityat roughly 3,600 and 3,000 per month, respectively, for lower doses
Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis
Many inhibitors also have off-target effects, which become more pronounced at high concentrations
Alternatively, we know that these medications reduce the risk of strokes and so it could be that they help by preventing vascular events that contribute to dementia. To explore the possible connection between Alzheimers and GLP-1 agonists, Novo Nordisk launched two phase 3 trials EVOKE and EVOKE plus in 2021
Sermorelin and BPC-157 serve different purposes